NCT04140526
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04140526
Title Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
Acronym PRESERVE-001
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OncoImmune, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
University of California at Davis Davis California 95817 United States Details
The Oncology Institute of Hope and Innovation Downey California 90241 United States Details
City of Hope Cancer Center Duarte California 91010 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Nuvance Health Norwalk Connecticut 06856 United States Details
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007 United States Details
Florida Cancer Specialists Atlantis Florida 33462 United States Details
University of Florida Health Cancer Center Gainesville Florida 32610 United States Details
Ocala Oncology Florida Cancer Affiliates Ocala Florida 34474 United States Details
AdventHealth Cancer Institute Orlando Florida 32804 United States Details
Memorial Cancer Institute Pembroke Pines Florida 33028 United States Details
Emory University Winship Cancer Institute Atlanta Georgia 30322 United States Details
Norton Health Lexington Kentucky 40202 United States Details
Greater Baltimore Medical Center Baltimore Maryland 21204 United States Details
The Center for Cancer and Blood Disorders Bethesda Maryland 20817 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Massachusetts General Hospital Boston Massachusetts 02215 United States Details
University of Michigan Medical Center Ann Arbor Michigan 48109 United States Details
Atlantic Healthcare System Morristown New Jersey 07960 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
The Ohio State University James Cancer Center Columbus Ohio 43210 United States Details
Zangmeister Cancer Center Columbus Ohio 43219 United States Details
Pennsylvania Cancer Specialists & Research Institute (Formerly Gettysburg Cancer Center) Gettysburg Pennsylvania 17325 United States Details
Prisma Health Greenville South Carolina 29605 United States Details
Tennessee Oncology Chattanooga Memorial Plaza Chattanooga Tennessee 37404 United States Details
Tennessee Oncology - Nashville Nashville Tennessee 37203 United States Details
Houston Methodist Cancer Center Houston Texas 77030 United States Details
Oncology Consultants Houston Texas 77030 United States Details
University of Utah Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
NEXT/Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
University of Washington / Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
Newcastle Private Hospital New Lambton Heights New South Wales 2305 Australia Details
Tasman Oncology Research Southport Queensland 4120 Australia Details
Cancer Research SA Adelaide South Australia 5000 Australia Details
Southern Oncology Clinical Research Unit Bedford Park South Australia 5042 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field